Corient Private Wealth
MGNX icon

Corient Private Wealth’s MacroGenics MGNX Stock Holding History

Corient Private Wealth’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
30,000
-1,820
-6% -$6.88K ﹤0.01% 2882
2026
Q1 		$92K Buy
31,820
+19,998
+169% +$42.7K ﹤0.01% 2704
2025
Q4 		$19K Sell
11,822
-2,802
-19% -$4.41K ﹤0.01% 2624
2025
Q3 		$24.6K Buy
+14,624
New +$23.7K ﹤0.01% 2524
2023
Q4 		– Sell
-11,738
Closed -$54.7K – 2316
2023
Q3 		$54.7K Hold
11,738
– – ﹤0.01% 2072
2023
Q2 		$62.8K Buy
+11,738
New +$72.4K ﹤0.01% 2007

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Corient Private Wealth's MGNX Position: Q2 2026 in Review

Corient Private Wealth reduced its MacroGenics (MGNX) stake by 5.7% in Q2 2026, selling an estimated $6.88K and leaving 30,000 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

Corient Private Wealth first reported a position in MGNX in Q2 2023 and has held it in 6 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Corient Private Wealth held 30,000 shares of MacroGenics worth $139K as of Q2 2026.
  • Corient Private Wealth sold 1,820 MacroGenics shares in Q2 2026, an estimated $6.88K.
  • MacroGenics made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2882 holding.
  • Corient Private Wealth first reported a position in MacroGenics in Q2 2023 and has held it in 6 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.